GSK Potential Fines In China Pale To Those It Could Face In U.S., U.K.
This article was originally published in PharmAsia News
Executive Summary
GlaxoSmithKline could face greater financial worries in the U.S. and the U.K. than in China for its alleged involvement in a bribery scandal half-way around the world.